Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals - 2Flash flooding causes highways to close to and from Eilat
- 3Hezbollah claims right to respond to killing of top commander
- 4Building Tough Connections: Individual Bits of knowledge on Association
- 5Revvity says it will exceed 2025 profit forecast range
- Iran begins cloud seeding to induce rain amid historic drought
- Figure out How to Adjust Work, Life, and an Internet based Degree
- Protester climbs on to balcony of Iranian embassy in London
- An Extended period of Voyaging Carefully: the World with Reason
- Orcas seen hunting great white sharks to eat their livers in drone footage recorded in Mexico
- Former 'Bachelorette' welcomes 1st baby via emergency c-section
- Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
- Anthony Joshua's driver charged over Nigeria crash that killed two
- The Main 10 Natural life Protection Associations
